Tempus AI saw a welcome improvement to its Relative Strength (RS) Rating on Monday, rising from 90 to 97.
This unique rating identifies technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the trailing 52 weeks matches up against all other stocks in our database.
Decades of market research reveals that the best stocks often have an RS Rating of over 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Tempus AI is trying to complete a cup without handle with a 77.00 buy point. See if it can break out in volume at least 40% above average.
The company posted 0% EPS growth in the latest quarterly report, while sales growth came in at 33%.
The company holds the No. 14 rank among its peers in the Medical-Research Equipment/Services industry group. Veracyte, Natera and Medpace Holdings are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
